Beta Bionics, Inc. Common Stock (BBNX) Stock Price

BBNXStock

$19.34+15.72%52W

Market Cap$870.10M

P/E—

PEG Ratio—

Div yield—

Beta1.09

BBNX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)33.72%

Price vs S&P 500 (4W)21.82%

VGM Score68.71

Book Value / Share (Quarterly)$5.70

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)724.29%

Cash Flow / Share (Quarterly)$-1.37

Price vs S&P 500 (YTD)-47.21%

Gross Margin (TTM)58.31%

Net Profit Margin (TTM)-61.32%

EPS (TTM)$-1.65

10-Day Avg Trading Volume1.22M

EPS Excl Extra (TTM)$-1.65

EPS (Annual)$-1.81

ROI (Annual)-25.45%

Gross Margin (Annual)55.40%

Cash / Share (Quarterly)$4.01

Revenue Growth QoQ (YoY)37.76%

ROA (Last FY)-22.27%

Revenue Growth TTM (YoY)94.09%

EBITD / Share (TTM)$-1.83

Operating Margin (TTM)-69.75%

Cash Flow / Share (Annual)$-1.27

P/B Ratio3.17x

P/B Ratio (Quarterly)2.72x

Net Income / Employee (Annual)$-174,300

EV / Revenue (TTM)6.46x

ROA (TTM)-23.25%

EPS Incl Extra (Annual)$-1.81

Current Ratio (Annual)8.66x

Quick Ratio (Quarterly)7.72x

3-Month Avg Trading Volume1.08M

52-Week Price Return15.72%

Revenue / Employee (TTM)$283,400

P/S Ratio (Annual)8.11x

Asset Turnover (Annual)0.30x

52-Week High$32.71

EPS Excl Extra (Annual)$-1.81

26-Week Price Return44.97%

Quick Ratio (Annual)7.73x

13-Week Price Return85.96%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.88x

Enterprise Value$769.10M

Asset Turnover (TTM)0.38x

Revenue / Employee (Annual)$238,700

Inventory Turnover (Annual)2.55x

Pretax Margin (Annual)-73.02%

Cash / Share (Annual)$4.94

3-Month Return Std Dev75.56%

Net Income / Employee (TTM)$-173,700

ROE (Last FY)-25.45%

EPS Basic Excl Extra (Annual)$-1.81

Receivables Turnover (TTM)7.59x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.65

Receivables Turnover (Annual)6.34x

ROI (TTM)-26.30%

P/S Ratio (TTM)6.83x

Revenue / Share (Annual)$2.47

Price vs S&P 500 (52W)-2.59%

Year-to-Date Return-35.25%

5-Day Price Return3.73%

EPS Normalized (Annual)$-1.81

Net Profit Margin (Annual)-73.02%

Month-to-Date Return53.78%

EBITD / Share (Annual)$-1.73

Operating Margin (Annual)-71.50%

EPS Basic Excl Extra (TTM)$-1.65

P/B Ratio (Annual)4.66x

Inventory Turnover (TTM)2.41x

Pretax Margin (TTM)-61.32%

Book Value / Share (Annual)$6.48

Price vs S&P 500 (13W)83.16%

Beta1.09x

Revenue / Share (TTM)$2.67

ROE (TTM)-26.30%

52-Week Low$8.80

vGradeD

gGradeA

mGradeA

vgmGradeB

BBNX Earnings Surprise History

Q2 25-0.27est. -0.47

Q3 25-0.33est. -0.41

Q4 25-0.19est. -0.38

Q1 26-0.36est. -0.45

Q2 26-0.36est. -0.56

BBNX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

4.12

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About Beta Bionics, Inc. Common Stock

Beta Bionics is a commercial-stage medical device company developing the iLet Bionic Pancreas, an automated insulin delivery system using adaptive closed-loop algorithms for people with insulin-dependent diabetes. The company's proprietary technology is designed to simplify diabetes management and improve patient outcomes by automating insulin dosing. Beta Bionics operates a focused business model centered on the development, manufacturing, and commercialization of the iLet platform.